Do you want to read an article? Please log in or register.
Glycoprotein A as a biomarker of pulmonary infection and inflammation in children with cystic fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
Pulmonary Fibrosis
Children with cystic fibrosis demonstrate no respiratory immunological, infective or physiological, consequences of vitamin D deficiency
J Cyst Fibros.
Thursfield RM, Naderi K, Leaver N, Rosenthal M, Alton EWFW, Bush A, Davies JC
doi: 10.1016/j.jcf.2018.02.011.
Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis
Thorax.
Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F
doi: 10.1136/
Pulmonary Fibrosis
Short-Term Effects of Elastic Chest Wall Restriction on Pulmonary Function in Children with Cystic Fibrosis
Respiration.
Roethlisberger K, Nyilas S, Riedel T, Wolfensberger J, Singer F, Latzin P
doi: 10.1159/000491094.
RECOMMENDED
Pulmonary Fibrosis
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis
Cochrane Database Syst Rev.
Smith S, Rowbotham NJ, Charbek E
doi: 10.1002/14651858.
RECOMMENDED
Pulmonary Fibrosis
BAL inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chest.
Ishak A, Stick SM, Turkovic L, Ranganathan SC, King L, Harrison J, Sly PD, Caudri D, Schultz A, AREST CF.
doi: 10.1016/j.chest.2020.06.044.
RECOMMENDED
Pulmonary Fibrosis
Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial
Am J Respir Crit Care Med.
Mayer-Hamblett N, Retsch-Bogart G, Kloster M, Accurso F, Rosenfeld M, Albers G, Black P, Brown P, Cairns A, Davis SD, Graff GR, Kerby GS, Orenstein D, Buckingham R, Ramsey BW; OPTIMIZE Study Group
doi: 10.1164/rccm.
RECOMMENDED
Pulmonary Fibrosis
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study
Lancet Respir Med.
McNamara JJ, McColley SA, Marigowda G, Liu F, Tian S, Owen CA, Stiles D, Li C, Waltz D, Wang LT, Sawicki GS
doi: 10.1016/S2213-2600(18)30460-0.
Pulmonary Fibrosis
Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis
Thorax.
Kopp BT, Thompson R, Kim J, Konstan R, Diaz A, Smith B, Shrestha C, Rogers LK, Hayes D Jr, Tumin D, Woodley FW, Ramilo O, Sanders DB, Groner JA, Mejias A
doi: 10.1136/thoraxjnl-
RECOMMENDED
Bronchi
Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Ther Adv Respir Dis.
Lommatzsch ST
doi: 10.1177/1753466620905272.